Trial Profile
Sitagliptin added to previously taken anti-diabetic agents on insulin- resistance and lipid profile: a two years study evaluation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Antihyperglycaemics
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 16 Oct 2012 New trial record
- 05 Oct 2012 Results presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.